World’s Largest Cell Therapy Manufacturing Operation Accelerated by Center for Breakthrough Medicines
CBM’s facilities currently provide biotechs with viral vector, cell therapy, and plasmid DNA manufacturing, as well as extensive process and analytical development and testing capabilities.
The state-of-the-art manufacturing facilities will be engineered and future-proofed to support a range of cell types and complex manufacturing processes, designed to maximize efficiency and minimize costs.
To facilitate the development of next-generation cell therapies specialized technologies will be implemented to allow for autologous manufacturing, high-fidelity gene-editing and a fully automated process.
To attain the specific manufacturing needs of the cell therapies industry CBM is working with academic institutions and innovator companies. Their aim is to lower costs, shorten timelines and scale manufacturing procedures to advance the development of these critical products and ultimately get them to patients.